Navigation Links
New Cancer “Growth Blocking Super Drug” Patents Filed
Date:2/8/2013

San Diego, CA (PRWEB) February 08, 2013

The pharmaceutical world has been racing for the cure for cancer for decades with what most experts agree is limited success. The current drugs are either so toxic and damaging to the body that many patients have to weigh the benefits of their use or the drugs are only designed to treat specific types of cancers and often only specific “strains” of specific cancers.

There is now an emerging world class sprinter in the race to create the “Super Drug” – Kalos Therapeutics. The “Super Drug” in the cancer world refers to a drug that may be used to treat multiple types of cancer and their various strains while avoiding the additional trauma often caused by chemotherapy, radiation and many of the current cancer drugs.

Kalos Therapeutics is an emerging biomedical company with the exclusive patent to develop the ANP (Atrial Natriuretic Peptide) family of peptides as a new mechanism for the treatment of cancer.

Kalos is pioneering an approach to cancer treatment by developing peptides made primarily in the heart, as a cytostatic therapeutic for treating aggressive cancers by engaging known pathway receptors more efficiently without the side effects associated with chemotherapeutic or small molecule compounds.

George Colberg, the CEO of Kalos Therapeutics, has amassed a who’s who dream team representing the best and brightest of the cancer and bio-tech worlds. More importantly is the fact that the team has the ability to think differently about what is the most effective way to treat cancer. It is that difference in thinking that appears to be producing a game changing cancer therapy.

Anti-Cancer Bio-technology

“Kalos has successfully leveraged the natural antiproliferative activity of the Atrial Natriuretic Peptide (ANP) family of peptides in our pat
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related biology technology :

1. University of Colorado Cancer Center Review Shows Long-term Side-effects of New, Targeted Therapies in Pediatric Cancer Patients
2. Transcreener Assays Highlighted for Challenging Microbial, Cancer and Epigenetic Drug Targets at SLAS 2013
3. Governor Cuomo Announces Continued Growth at Roswell Park Cancer Institute with Regional Economic Development Council Funding; RPCI Center for Personalized Medicine established with CTG (NASDAQ: CTGX) serving as its technology partner
4. Transition in cell type parallels treatment response, disease progression in breast cancer
5. Two University of Colorado Cancer Center Studies Show that Silibinin, Found in Milk Thistle, Protects Against UV-Induced Skin Cancer
6. Navigating Cancer Announces Jeff Oberlander as VP, Engineering
7. Tracking the Battle Against Breast Cancer With New Market Research
8. Caris Life Sciences Adds Next-Generation Sequencing to Enhance Evidence-Based Tumor Profiling Service for Cancer Patients
9. WaferGens MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
10. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
11. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  EMD Serono, the U.S. ... , announced today the appointment of Frederick ... Neurology and Immunology. In this capacity, he will lead ... development projects and collaborations for Rebif ® (interferon ... pipeline. Dr. Munschauer joins EMD Serono ...
(Date:4/1/2015)... 2014 /CNW/ - Canada,s Research-Based Pharmaceutical ... newly released report on Cost Drivers of Public Drug Plans ... to the report, the rates of change in drug costs ... of -0.8 percent in 2012/13 for a number of select ... examines the costs of medicines without considering their overall impact ...
(Date:4/1/2015)... April 1, 2015 Synthetic Biologics, Inc. ... for serious infections and diseases, with a focus ... data supporting the development of SYN-004, the Company,s ... (IV) antibiotics within the gastrointestinal (GI) tract and ... for the prevention of C. difficile ...
(Date:4/1/2015)... 01, 2015 The concept of “spot reducing” ... dollar industry. Founder of Fasciology, Ashley Black, says that even ... fat, instead of having to wait for the whole fat ... “ prior to fat cooling procedures, the only well ... was liposuction, which is a highly invasive procedure.” It is ...
Breaking Biology Technology:EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 2EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 3EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 4EMD Serono Appoints Frederick E. Munschauer M.D., FAAN to Vice President of Medical Affairs, Neurology and Immunology 5Rx&D responds to PMPRB report: overall impact of medicines must always be considered 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 2Hybrid Health Guru, Ashley Black, announces that her invention The FasciaBlaster™ rivals the “fat cooling” procedures that reduce exercise and diet resistant fat pockets. 3
... , , , , , , ... Rohrer, Eppendorf AG, Germany , Lars-Erik Peters, Eppendorf 5Prime, USA , ... , The reliability of a PCR* experiment is dependent on ... for a successful , PCR is efficient sample preparation, ...
... , , , , , ... of Biology, University of California San Diego, La Jolla, , CA 92093-0349 ... , , Introduction ... colleagues , at Stanford University, makes use of a robotic ...
... , , , Multiporator , , , , , , ... Protocol No. 4308 915.040 11/2000 , , ... , , Cell line , ... Transfection with , Plasmid pEGFP-C1 (in bidistilled H 2 O), , ...
Cached Biology Technology:Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 2Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 3Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 4Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 5Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 6Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 7Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 8Amplification of Mouse cDNAs for Microarrays Using the Eppendorf , MasterTaq Kit 9U-266 2
(Date:3/18/2015)... 2015 As mobile payments become more ... wallets and apps continue to be introduced into the market ... mobile payment industry in focus today are:  NXT-ID, Inc. (NASDAQ: ... BABA ), Apple Inc. (NASDAQ: AAPL ), ... (NASDAQ: FB ) NXT-ID, Inc. (NASDAQ: ...
(Date:3/12/2015)... FAIRFAX, Va. , March 12, 2015 ... company and a member of the Texas Instruments Design ... Chandrababu Naidu has demonstrated its IriShield USB MK2120U ... iris scanning facility for pension distribution. ... and assembled to be marketed in India ...
(Date:3/11/2015)... BOSTON , March 11, 2015   ... of its platform to scientifically measure and harness ... characteristics to real-time biometrics and objective measurements of ... of music at scale in large populations. It ... scientists, technologists and clinicians perform rigorous studies and ...
Breaking Biology News(10 mins):Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 2Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 3Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 4Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 5Revolutionary Smart Wallet & Mobile Payment Choices Change the Game for Consumers - Company Begins Shipping Newest Digital Wallet to Customers 6Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 2Introducing The Sync Project, a Global Collaboration Harnessing the Scientific Potential of Music for Health 3
... Hospital of Philadelphia collaborated with European gene therapy ... young children with Wiskott-Aldrich syndrome, a very rare ... Orange, M.D., Ph.D., an expert in Wiskott-Aldrich syndrome ... the study, led by German researcher Christoph Klein, ...
... Therapeutics (NYSE Amex: CXM ) reported on ... research at the American Heart Association 2010 Annual Meeting ... in Chicago, IL.  The new findings showed that coronary ... delivery to the heart, which is used in the ...
... data have suggested that omega-3 fatty acid supplements, such as ... randomized trial with more than 600 patients finds that treatment ... atrial fibrillation over six months, according to a study that ... . The study is being released early online because it ...
Cached Biology News:Children's Hospital of Philadelphia collaborates in gene therapy success in an immune disorder 2Children's Hospital of Philadelphia collaborates in gene therapy success in an immune disorder 3Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 2Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 3Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 4Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 5Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 6Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 7Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development 8Use of omega-3 does not appear to reduce recurrence of atrial fibrillation 2
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Request Info...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
2-min, single-step add-mix-measure assay for luciferase expression and HTS in mammalian cells. Linear detection range: 2 fg to 46 ng luciferase....
Biology Products: